Optimal Personalised Treatment of early breast cancer using Multi-parameter Analysis

  • Taking Part in OPTIMA
  • OPTIMA Recruiting Sites
  • The OPTIMA Team
  • Contact Us
  • Taking Part in OPTIMA
    • COVID-19 and OPTIMA
    • About treatment for breast cancer
    • About OPTIMA
    • Who can take part?
    • What's involved in taking part?
    • Patient and public engagement (PPI)
    • More information
    • Is my local hospital recruiting?
    • Privacy Statement
  • OPTIMA Sites
    • COVID-19 and OPTIMA
    • Essential dcuments
    • Newsletters
    • Administering OPTIMA
    • Qualitative Recruitment Study
    • Recruiter training and support
    • Publications
    • OPTIMA governance
  • The OPTIMA Team
  • Contact Us

  • Essential Documents
  • Newsletters
  • Administering OPTIMA
  • Qualitative Recruitment Study
  • Recruiter training and support
  • Publications
  • OPTIMA Governance

Recruiter training and support

Training and support documents

  • OPTIMA Remote Consent Procedure_v2.0 2021-07-14
  • OPTIMA Recruitment and Informed Consent Guidance v2.0 2018-03-28
  • OPTIMA Recruiter Tips Engaging With Patient Preferences v1.0 2019-06-12
  • The OPTIMA Guide for surgeons v2.0 2021-10-25
  • The OPTIMA Guide for Breast Nurse Specialists v1.0 2018-08-16
  • OPTIMA Site Sample Collection SOP v8.0 2021-07-27

      'Lunch with OPTIMA' Slides

      Specific updates:
      • Lunch with OPTIMA - COVID19 update (presented Aug/Sept 2020)
      • Lunch with OPTIMA - Protocol v7.0 update (presented Oct/Nov 2020)
      • Lunch with OPTIMA - RxPONDER update (presented Jan/Feb 2021)
      • Lunch with OPTIMA - SABCS update and RxPONDER (presented Feb 2022)
      • Lunch with OPTIMA - ASCO update (presented Aug 2022)
      • Lunch with OPTIMA - Pathology Session (presented Oct/Nov 2022)
      General Training:
      • Lunch with OPTIMA - Tissue Transit form Training
      • Lunch with OPTIMA - SIV refresher'

      OPTIMA Investigator Meeting documents

      • OPTIMA Investigator Meeting - 21-06-2022

      © 2019 OPTIMA

      ABS Badge The OPTIMA Study is funded by National Institute for Health Research (NIHR), Programme (project reference 10/34/501). The information contained in this website is for general information about the OPTIMA study and is provided by the University of Warwick Clinical Trials Unit & University College London. The views expressed are those of the author(s) and are not necessarily those of NIHR or the Department of Health and Social Care or representative of the views of the funder, sponsor or other participating organisations. Trial Registration Number ISRCTN42400492